Conditional disruption mTORC2 in epidermis by inducible deletion Rictor is sufficient to delay tumor development and trigger regression of established tumors (Carr et al., 2015), indicating that mTORC2 activation is essential for SCC development and inhibition of mTORC2 may be valuable in tumor therapy. This evidence concerns the gene RICTOR and neoplasm.